he detection of circulating plasma cells may improve tThe Revised International Staging System (R‐ISS) risk stratification of patients with newly diagnosed multiple myeloma Redazione 6 Maggio 2021 ...
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL Redazione 6 Maggio 2021 ...
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial Redazione 6 Maggio 2021 ...
Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia Redazione 22 Aprile 2021 ...
A brief rituximab, bendamustine, mitoxantrone (R‐BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL) Redazione 22 Aprile 2021 ...
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial Redazione 22 Aprile 2021 ...
Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma—Reply Redazione 22 Aprile 2021 ...
The need for ethical guidance for the use of patient-reported outcomes in research and clinical practice Redazione 22 Aprile 2021 ...
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination Redazione 22 Aprile 2021 ...